Medpace Holdings, Inc.
MEDP
#1334
Rank
$17.279 B
Marketcap
United States
Country
$619.05
Share price
2.24%
Change (1 day)
23.38%
Change (1 year)
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries;…
Key Metrics
Trailing P/E
35.77
Forward P/E
31.57
EPS (TTM)
$17.04
Forward EPS
$19.31
Price / Book
39.21
EV / EBITDA
27.5x
Beta
1.15
Dividend Yield
—
Return on Equity
162.15%
Return on Assets
20.10%
Debt / Equity
33.22
Current Ratio
0.73
Gross Margin
72.35%
Operating Margin
20.76%
Net Profit Margin
17.66%
Free Cash Flow
$510.397M
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 18
+0.21%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$2.530B
Latest Net Income$451.123M
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Medpace Holdings, Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
MEDP
No recent news available. Set FINNHUB_API_KEY to enable news.
